Edition:
United States

Aquinox Pharmaceuticals Inc (AQXP.OQ)

AQXP.OQ on NASDAQ Stock Exchange Global Market

12.63USD
19 Apr 2018
Change (% chg)

$-0.66 (-4.97%)
Prev Close
$13.29
Open
$13.24
Day's High
$13.24
Day's Low
$12.50
Volume
15,952
Avg. Vol
36,880
52-wk High
$16.85
52-wk Low
$10.03

Chart for

About

Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology. The Company's primary focus is anti-inflammatory product candidates targeting the Src Homology 2 (SH2)-containing inositol-5-phosphatase 1 (SHIP1) enzyme,... (more)

Overall

Beta: --
Market Cap(Mil.): $312.19
Shares Outstanding(Mil.): 23.49
Dividend: --
Yield (%): --

Financials

  AQXP.OQ Industry Sector
P/E (TTM): -- 30.61 33.50
EPS (TTM): -2.24 -- --
ROI: -42.98 13.57 13.17
ROE: -43.10 15.25 14.98

BRIEF-Aquinox Provides Enrollment Update For Leadership 301 Clinical Trial Of Rosiptor

* AQUINOX PROVIDES ENROLLMENT UPDATE FOR LEADERSHIP 301 CLINICAL TRIAL OF ROSIPTOR

Feb 09 2018

BRIEF-‍Aquinox Statement On Fda Advisory Committee Meeting To Discuss Interstitial Cystitis/Bladder Pain Syndrome​

* ‍AQUINOX STATEMENT ON FDA ADVISORY COMMITTEE MEETING TO DISCUSS INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME​

Dec 07 2017

BRIEF-Aquinox Pharmaceuticals qtrly ‍net loss per share $0.50​

* Aquinox Pharmaceuticals announces third quarter 2017 financial results

Nov 08 2017

Earnings vs. Estimates